跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

How AI Is Changing Cancer Drug Discovery

1Why Cancer Drug Discovery Is So Hard2What AI Can and Cannot Do Here3Finding the Right Target4Designing Molecules with AI5Testing, Trials, and Real-World Impact6What's Next and What to Watch
What's Next and What to Watch

Telling Progress from Hype, and Where to Follow It

3 / 3
Look at the two columns as two ways of describing the very same result. The credible version names the compound, gives the phase and the number of patients, says what was measured and against what comparison, and admits what is still unknown. The promotional version leads with a percentage, uses the word cure without a patient outcome, and treats model accuracy as if it were a clinical result. The difference is not the science; it is whether the claim can be checked. So when you meet a headline, ask three things: what was actually tested, in how many people, and compared against what. If the honest answer is that a model did well on historical data, you are looking at a research result, not a treatment. To follow the field yourself, trial registries show what is genuinely running in people, peer-reviewed journals publish the methods and the caveats, and company pipeline pages reveal which candidates advanced and which quietly stopped.
0:00 / 0:00

How the same result reads two ways

Credible progress

  • Names the specific compound or trial
  • States the phase and the number of patients
  • Says what was measured and against what comparison
  • States the limitations openly

Hype

  • Leads with a percentage and no context
  • Uses 'cure' or 'breakthrough' without a patient outcome
  • Cites model accuracy as if it were a clinical result
  • Omits what is still unknown

Three questions to ask of any headline

  • What exactly was tested — a model, a molecule, or a treatment in people?
  • In how many people, and were they representative of the patients who would actually use it?
  • Compared against what — an existing treatment, a placebo, or nothing at all?

Where to follow the field

  • Trial registries: what is actually running and still recruiting in people
  • Peer-reviewed journals: results published with methods and stated limitations
  • Company pipeline pages and conference presentations: which candidates moved forward and which stopped
上一页3 / 3完成

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion